ProCE Banner Activity

Overview of HER2 and Treatment of HER2-Positive Early Breast Cancer


Download these slides from an expert-led webinar on the latest data for the treatment of HER2-positive early breast cancer.

Released: February 28, 2023



Aditya Bardia

Aditya Bardia, MD, MPH, FASCO

Professor of Medicine
Geffen School of Medicine at UCLA
Director, Breast Oncology Program
Assistant Chief (Translational Research)
Division of Medical Oncology
Director of Translational Research Integration
UCLA Health Jonsson Comprehensive Cancer Center
Los Angeles, California

Erika P. Hamilton

Erika P. Hamilton, MD

Director, Breast Cancer Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from Puma Biotechnology, Inc. and Seagen Inc.

Puma Biotechnology, Inc.

Seagen Inc.